Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base?
Reports
Abernethy, AP; Allen LaPointe, N; Wheeler, JL; Irvine, RJ; Patwardhan, M; Matchar, D
August 28, 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Publication Date
August 28, 2009
Citation
APA
Chicago
ICMJE
MLA
NLM
Abernethy, A. P., Allen LaPointe, N., Wheeler, J. L., Irvine, R. J., Patwardhan, M., & Matchar, D. (2009). Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base?
Abernethy, A. P., Nancy Allen LaPointe, J. L. Wheeler, R. J. Irvine, M. Patwardhan, and D. Matchar. “Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base?,” August 28, 2009.
Abernethy AP, Allen LaPointe N, Wheeler JL, Irvine RJ, Patwardhan M, Matchar D. Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? 2009 Aug.
Abernethy, A. P., et al. Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? 28 Aug. 2009.
Abernethy AP, Allen LaPointe N, Wheeler JL, Irvine RJ, Patwardhan M, Matchar D. Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? 2009 Aug.
Publication Date
August 28, 2009